• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Replication regulation of hepatitis C virus by cyclosporin A

Research Project

Project/Area Number 08670624
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionShowa University

Principal Investigator

YOSHIBA Shinsho  Showa University, school of Medicine. A. Prof, 医学部, 助教授 (20010457)

Co-Investigator(Kenkyū-buntansha) INOUE Kazuaki  Tokyo Metropolitan Institute of Medical Science Researcher, 放射線医学研究部門, 研究員 (90232529)
SEKIYAMA Kazuhiko  Showa University, school of Medicine Lecturer, 医学部, 講師 (90211391)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1997: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1996: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsHCV / cyclosporin A / calcineurin / proline_peptidyltransisomerase / HCV / インターフェロン / IMY細胞 / サイクロフィリン / C型慢性肝炎 / アポトーシス
Research Abstract

Current therapy of chronic hepatitis C with a 6 months course of alpha interferon shows limited effectiveness for patients with chronic hepatitis C. In particular, more effective therapy is needed to treat patients who have a high serum level of HCV RNA. We previously reported that combination of interferon and cyclosporin A (CsA) was more effective than interferon alone (4th international meeting on hepatitis C virus and related virus). Antiviral effect of CsA on HCV has not been fully elucidated. In the present study, we examined whether CsA has an antiviral effect on HCV using cultured cell line.
We used IMY-N9 cell which was hybrid cell line from human hepatocytes and HepG2 cells to propagate HCV. Infection was performed by 1 hour incubation of IMY-N9 cell suspension with an inoculum in serum free medium. Following exposure, cells were washed twice with Williams medium and seeded on 48 well plate. CsA was dissolved with dimethyl sulfoxide (DMSO). Final concentration of CsA and DMSO … More were 100ng/ml, 1000ng/ml, 10000ng/ml and 0.01%. We confirmed that CsA and DMSO were not toxic for IMY-N9 cell using alamar blue assay. On day 1, medium was changed and added each concentration of CsA (CsA group), DMSO alone (vehicle control group) or none (control group). Cells were harvested on day 2, 4, 6 and 8 and stored -80C until use. HCV RNA in cultured cells were quantitatively determined by RTD-PCR based on Taq Man chemistry. Immediately after seeding, HCV RNA in cultured cells was 2x103 copies/well. On day 2 and 4, HCV RNA in cultured cells decreased to 4x102 copies/well in the presence or absense of CsA or DMSO. On day 6, HCV RNA in control and vehicle control groups increased to 1.3-1.5x104 copies/well. In CsA groups (100ng/ml, 1000ng/ml and 10000ng/ml), HCV RNA were reduced to 80%, 40% and 20% of control level, respectively. On day 8, HCV RNA returned to 3-5x102 copies/well in all groups. Propagation of HCV seems to be inhibited by CsA. Further study is needed to clarify the action of CsA. Less

Report

(3 results)
  • 1998 Final Research Report Summary
  • 1997 Annual Research Report
  • 1996 Annual Research Report
  • Research Products

    (28 results)

All Other

All Publications (28 results)

  • [Publications] Abe A, Inoue K, Yoshiba M, et al.: "Quantitation of hepatitis B virus DNA using real time detectin polymerase chain reaction"Jarnal of Clinical Microbiology. (印刷中). (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Inoue K, Yoshiba M, et al.: "Possible association betweein serum GB virus C RNA level and disease activity in fulminant hepatitis type G"Jarnal of Hepatology. 30(印刷中). (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Inoue K, Yoshiba M, et al.: "Real-Time Detection System for Quantification of Hepatitis C"Gastroenterology. 116. 636-642 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshiba M.: "Clinical and Moleclar Virological Differences Between Fulminant Hepatic Failures Following Acute and Chronic Infection with Hepatitis B Virus"Jarnal of Medical Virology. 50. 35-51 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshiba M.: "Recent Progress in the Treatment of Fulminant Hepatic Failure in Japan"J Infect Chemother. 4. 41-49 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hakozaki Y, Yoshiba M, et al.: "Current Issues in Interferon Treatment for Chronic Hepatitis C and Characterization of Incomplete Responders"Gastroenterology International. 1997-53 (10(2))

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Abe A, Inoue K, Yoshiba M, et al.: "Quantitation of hepatitis B virus DNA using real time detection polymerase chain reaction"Journal of Clinical Microbiology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Inoue K, Yoshiba M, et al.: "Possible association between serum GB virus C RNA level and disease activity in fulminant hepatitis type G"Journal of Hepatology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Inoue K, Kohara M, et al.: "Real-Time Detection System for Quantification of Hepatitis C Virus Genome"Gastroenterology. 116. 636-642 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshiba M.: "Clinical and Molecular Virological Differences Between Fulminant Hepatic Failures Following Acute and Chronic Infection with Hepatitis B virus"Journal of Medical Virology. 50. 35-51 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshiba M.: "Recent Progress in the Treatment of Fulminant Hepatic Failure in Japan"J Infect Chemother. 4. 41-49 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hakozaki Y, Yoshiba M, et al.: "Current Issues in Interferon Treatment for Chronic Hepatitis C and Characterization of Incomplete Responders"GastroenterologyInternational. 10 (2). 53-59 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshiba M.: "Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology" The Lancet. 346(8983). 1131-1132 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshiba M.: "GBV-C in the aetiology of fulminant hepatitis" The Lancet.347(8994). 120-121 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshiba M.: "Hepatitis GB Virus C" N Engl J Med. 335(18). 1392-1393 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshiba M.: "Favorable effect of New Artificial Liver Support on Survival of Patients with Fulminant Hepatic Failure" Artif Organs. 20(11). 1169-1172 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshiba M.: "Chronic Hepatitis A with Persistent Viral Replication" J Med Virol. 50. 322-324 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Hakozaki Y, Yoshiba M, et al.: "Current Issues in Interferon Treatment for Chronic Hepatitis C and Characterization of Incomplete Responders" Gastroenterol Intern.10(2). 53-59 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 与芝 真: "一目でわかる肝臓病学" メディカル・サイエンス・インターナショナル, 89 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] 与芝 真: "ベテランに学ぶ 肝胆膵疾患の診療のコツ" メディカル・サイエンス・インターナショナル, 470 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshiba M.: "Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology" The Lancet. 346(8983). 1131-1132 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshiba M.: "GBV-C in the aetiology of fulminant hepatitis" The Lancet. 347(8994). 120-121 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshiba M.: "Hepatitis GB virus C" N Engl J Med. 335(18). 1392-1393 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshiba M.: "Favorable Effect of New Artificial Liver Support on Survival of Patients with Fulminant Hepatic Failure" Artif Organs. 20(11). 1169-1172 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshiba M.: "Chronic Hepatitis A with Persistent Viral Replication" J Med Virol. 50. 322-324 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshiba M.: "Type C and G fulminant fepatitis in Japan" Elsevier Science B.V.25-30 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 与芝 真: "一目でわかる肝臓病学" メディカル・サイエンス・インターナショナル, 89 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 与芝 真: "ウイルス肝炎の話" 自費出版, 27 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi